Cardio-Oncology Heidelberg
Translational research at the interface of heart and cancer – from the cardiomyocyte to the patient.
Explore our research →Translational research
From preclinical models to clinical application.
Clinical care
Certified specialist outpatient clinic since 2016.
Early-career support
Doctoral theses, clerkships & open positions.
Modern cancer therapies can harm the heart. We investigate the molecular mechanisms of this cardiotoxicity and translate them into better diagnostics and cardioprotective strategies.
More about us →Clinical Research
ICI-associated myocarditis, cardiac imaging, biomarkers (HEartCORE) and standardized care pathways.
Learn more →
Basic Research
Anthracycline cardiotoxicity, cardiac epigenetics, the inflammasome, nuclear receptors and metabolism.
Learn more →
Imaging & Biomarkers
FAPI-PET and cardiac MRI for early detection of ICI-therapy related cardiotoxicity, plus biomarkers for risk stratification.
Learn more →Hector Foundation funds research into cancer immunotherapy and the heart with €1.3 million
Read the press release →New manuscript on mortality of acute coronary syndrome in cancer patients
Read the paper →Circulating musclin, skeletal muscle function and subclinical cardiac dysfunction in cancer patients
Read the paper →DZHK „Paper of the Month“
Nomination for the Circulation paper on biomarkers in ICI myocarditis.
Young Investigator Award
2nd prize (D. Finke), Dutch-German Joint Meeting of the Molecular Cardiology Working Groups.
Science Prize
Josef Freitag Foundation (D. Finke).
Hector Foundation
€1.3 million funding for heart–cancer immunotherapy research.
Curriculum & textbook
First German-language textbook + curriculum „Oncological Cardiology“.
Connected with leading centers in research and clinical care.